# Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy

> **NCT00496457** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 159 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** Experimental
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT00496457
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2016-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496457, "Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00496457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*